Share price

I expected a pull back to 60 cents. But here at 47 cents is crazy. Not one justification that I can think of that stands up to scrutiny. Yes lots of reasons, I get that, but on investigation none of them that make any real sense for this sudden drop. Nothing has changed other than new information that clearly spells out that the Cantrixil is very safe with hardly ony dose limiting AE. Secondly that it works as a monotherapy at least to SD. When you consider the low therapeutic dose that were given and the state of the patients, it looks even better. Part B given at maximum therpatice doses is sounding exciting to me at least. Why the hell some investors are selling on that news is mind boggling.